No Result

View All Result

No products in the cart.

Home StudyGraphics

#VisualAbstract: Trastuzumab emtansine monotherapy is noninferior to standard neoadjuvant therapy for ERBB2+ breast cancer

byTeddy Guo

September 8, 2021

in StudyGraphics

Reading Time: 1 min read

#VisualAbstract: Efficacy and safety of adalimumab in conjunction with surgery in moderate to severe hidradenitis suppurativa

RelatedReports

Variability in interpretation of breast biopsy slides associated with low verification of atypia and ductal carcinoma in situ

Chronic Disease

Statins do not increase breast cancer risk in postmenopausal women

April 7, 2026

Stochastic resonance stimulation may decrease apnea of prematurity

Weekly Rewinds

2 Minute Medicine Rewind April 6, 2026

April 6, 2026

High frequency of germline mutations observed in triple negative breast cancers

The Scan by 2 Minute Medicine®

Susie Wiles’ breast cancer diagnosis drives national screening surge

March 25, 2026

Artificial Intelligence

The Scan by 2 Minute Medicine®: Susie Wiles breast cancer diagnosis drives national screening surge, Jensen Huang’s GTC keynote turns healthcare AI into a pop-culture phenomenon, landmark ACSM guidelines simplify resistance training for longevity, and consumer alert issued for high-pressure cosmetic surgery chains

March 25, 2026

Updated USPSTF guidelines favor treatment of mild gestational diabetes

Novel macrophage-regulating cream demonstrated superior therapeutic efficacy for the treatment of diabetic foot ulcers compared to standard absorbent dressing

$The STORM trial: treatment refractory multiple myeloma patients experience response with selinexor$

Biologic teclistamab shows promise in treatment of refractory multiple myeloma in phase 1 drug study

Sleep duration, sleepiness, chronotype have variable associations with teen self-regulation

Association of sleep duration with all-cause mortality in East Asian adults

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports